[Facioscapulohumeral muscle dystrophy and heart disease]

P Emmrich1, V Ogunlade, T Gradistanac

  • 1Selbst. Abt. für Neuropathologie, Institut für Pathologie des Universitätsklinikums Leipzig (AöR), Liebigstr. 26, 04103 Leipzig, Germany.

Zeitschrift Fur Kardiologie
|May 4, 2005
PubMed

Insights

Cardiac insufficiency can occur in facio-scapulohumeral muscular dystrophy (FSHD). Autopsy revealed cardiac muscular involvement as the cause of death in an FSHD patient, suggesting a link between FSHD and heart disease.

Area of Science:

  • Cardiology
  • Neurology
  • Genetics

Context:

  • Cardiac involvement is recognized in various musculoskeletal disorders.
  • Facio-scapulohumeral muscular dystrophy (FSHD) has not been previously associated with cardiac complications.
  • Understanding the full spectrum of FSHD manifestations is crucial for patient care.

Purpose:

  • To investigate potential cardiac involvement in facio-scapulohumeral muscular dystrophy (FSHD).
  • To present a case study of a patient with FSHD experiencing progressive cardiac insufficiency.
  • To analyze the cardiac pathology in an FSHD patient post-mortem.

Summary:

  • A 71-year-old woman with FSHD presented with progressive cardiac insufficiency.
  • Molecular analysis confirmed FSHD in one of her affected daughters.
  • Autopsy revealed cardiac muscular involvement with histological changes similar to primary cardiomyopathy, identified as the cause of death.

Impact:

  • This case highlights cardiac disease as a potential, previously unrecognized, complication of FSHD.
  • Findings suggest the need for cardiac monitoring in FSHD patients.
  • The study expands the understanding of the clinical and pathological spectrum of FSHD.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...